MAIN DRUG-METABOLIZING ENZYME-SYSTEMS IN HUMAN NON-HODGKINS-LYMPHOMAS SENSITIVE OR RESISTANT TO CHEMOTHERAPY

被引：17

作者：

RIBRAG, V ^{[1
]}

MASSAAD, L ^{[1
]}

JANOT, F ^{[1
]}

MORIZET, J ^{[1
]}

GOUYETTE, A ^{[1
]}

CHABOT, GG ^{[1
]}

机构：

[1] INST GUSTAVE ROUSSY,DEPT PHARMACOTOXICOL & PHARMACOGENET,INSERM,U140,F-94805 VILLEJUIF,FRANCE

来源：

LEUKEMIA & LYMPHOMA | 1995年 / 18卷 / 3-4期

关键词：

DRUG-METABOLIZING ENZYMES; NON-HODGKINS LYMPHOMAS;

D O I：

10.3109/10428199509059622

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Non-Hodgkin's lymphomas (NHL) are one of the most chemosensitive human malignancies. Complete response (CR) is often achieved, but many patients relapse and a second CR is difficult to obtain because of the development of chemoresistance. In an attempt to better understand the biology and the chemosensitivity of these lymphoid tumors, we assessed the main drug-metabolizing enzyme systems in normal lymphocytes, chemosensitive NHL and chemoresistant NHL. Cytochromes P-450(1A1/A2, 2B1/B2, 2C8-10, 2E1, 3A4), epoxide hydrolase and glutathione S-transferases (GST-alpha, -mu, -pi) were assayed by immunoblotting. UDP-glucuronosyltransferase, beta-glucuronidase, sulfotransferase, sulfatase, GST activity, and glutathione (GSH) content, were determined by spectral assays, Results showed the absence of all probed cytochromes P-450 in normal lymphocytes and NHL cells tested. GST activity was significantly lower in chemoresistant NHL compared to normal lymphocytes. GST-alpha was not detected in either normal lymphocytes or NHL cells. GST-pi was the predominant isoenzyme, and GST-mu was not detected in chemosensitive NHL. GSH content was significantly lower in chemoresistant NHL compared to other lymphoid tissues tested. The conjugating enzymes UDP-glucuronosyltransferase and sulfatase were similar in either chemoresistant NHL compared to chemosensitive NHL. The activity of the hydrolytic enzyme beta-glucuronidase was lower in chemoresistant compared to chemosensitive NHL, whereas sulfatase was higher in sensitive NHL compared to normal lymphocytes. Epoxide hydrolase was not detected in either normal or NHL cells tested. In conclusion, these studies did not show any cytochrome P-450 in human lymphoid cells tested, but pointed out noteworthy differences for other enzyme systems tested. These data are of importance to further understand the mechanisms of drug resistance in human NHL.

引用

页码：303 / 310

页数：8

共 41 条

[1]

De Vita V.T., Hellman S., Rosenberg S.A., Cancer, principles and practice of oncology, Second edition., (1985)

[2]

Fisher R.I., Gaynor E.R., Dahlberg S., Oken M.M., Grogan T.M., Mize E.M., Glick J.H., Coltman C.A., Miller T.P., Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma, N. Engl, J. Med., 328, pp. 1002-1006, (1993)

[3]

De Vita V.T., Hubbard S.M., Longo D.L., The chemotherapy of lymphomas: looking back, moving forward—The Richard and Hinda Rosenthal Foundation Award Lecture, Cancer Res., 47, pp. 5810-5824, (1987)

[4]

Weick J.K., Dahlberg S., Fisher R.I., Dana B., Miller T.P., Balcerzak S.P., Pierce H.I., Combination chemotherapy of intermediaire-grade and high-grade non-Hodgkin's lymphoma with MACOP-B: A Southwest Oncology Group study, J. Clin. Oncol., 9, pp. 748-753, (1991)

[5]

Yi P.I., Coleman M., Saltz L., Norton L., Topilow A.A., Adler K., Bernhardt B., Chemotherapy for large cell lymphoma: A status update, Semin. Oncol., 17, pp. 60-73, (1990)

[6]

Guengerich F.P., Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy, Cancer Res., 48, pp. 2946-2954, (1988)

[7]

El Mouelhi M., Didolkar M.S., Elias E.G., Guengerich F.P., Kauffman F.C., Hepatic drug-metabolizing enzymes in primary and secondary tumors of human liver, Cancer Res., 47, pp. 460-466, (1987)

[8]

Clarke L., Waxmann D.J., Oxydative metabolism of cyclophosphamide: identification of the hepatic monooxygenase catalyst of drug activation, Cancer Rex, 49, pp. 2344-2350, (1989)

[9]

Cowan K.H., Batist G., Tulpule A., Sinha B.K., Myers C.E., Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats, Proc. Natl. Acad. Sci., 83, pp. 9328-9332, (1986)

[10]

Wolf R.C., Macpherson J.S., Smyth J.F., Evidence for the metabolism of Mitozantrone by microsomal glutathione transferases and 3-methylcholantrene glucuronosyl transferases, Biochem. Pharmacol., 35, pp. 1577-1581, (1986)

← 1 2 3 4 5 →